BNP Paribas Financial Markets’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1 | Sell |
3
-14
| -82% | -$7 | ﹤0.01% | 5894 |
|
|
2026
Q1 | $10 | Sell |
17
-3
| -15% | -$2 | ﹤0.01% | 5766 |
|
|
2025
Q4 | $13 | Hold |
20
| – | – | ﹤0.01% | 5684 |
|
|
2025
Q3 | $19 | Hold |
20
| – | – | ﹤0.01% | 5503 |
|
|
2025
Q2 | $26 | Buy |
20
+17
| +567% | +$17 | ﹤0.01% | 5382 |
|
|
2025
Q1 | $3 | Hold |
3
| – | – | ﹤0.01% | 5360 |
|
|
2024
Q4 | $3 | Hold |
3
| – | – | ﹤0.01% | 5378 |
|
|
2024
Q3 | $4 | Hold |
3
| – | – | ﹤0.01% | 4131 |
|
|
2024
Q2 | $2 | Hold |
3
| – | – | ﹤0.01% | 4031 |
|
|
2024
Q1 | $3 | Hold |
3
| – | – | ﹤0.01% | 4020 |
|
|
2023
Q4 | $3 | Hold |
3
| – | – | ﹤0.01% | 3993 |
|
|
2023
Q3 | $6 | Hold |
3
| – | – | ﹤0.01% | 3894 |
|
|
2023
Q2 | $11 | Hold |
3
| – | – | ﹤0.01% | 3893 |
|
|
2023
Q1 | $10 | Sell |
3
-346
| -99% | -$1.04K | ﹤0.01% | 3819 |
|
|
2022
Q4 | $541 | Hold |
349
| – | – | ﹤0.01% | 3854 |
|
|
2022
Q3 | $475 | Sell |
349
-3,061
| -90% | -$5.98K | ﹤0.01% | 4524 |
|
|
2022
Q2 | $7.47K | Sell |
3,410
-341
| -9% | -$783 | ﹤0.01% | 3779 |
|
|
2022
Q1 | $12K | Sell |
3,751
-5,227
| -58% | -$18.7K | ﹤0.01% | 3780 |
|
|
2021
Q4 | $37.6K | Buy |
8,978
+1,383
| +18% | +$7.76K | ﹤0.01% | 3786 |
|
|
2021
Q3 | $61.7K | Buy |
7,595
+6,120
| +415% | +$49.7K | ﹤0.01% | 3451 |
|
|
2021
Q2 | $11.1K | Sell |
1,475
-3,839
| -72% | -$32.3K | ﹤0.01% | 3697 |
|
|
2021
Q1 | $46.1K | Sell |
5,314
-2,066
| -28% | -$19.7K | ﹤0.01% | 3629 |
|
|
2020
Q4 | $58.8K | Sell |
7,380
-1,728
| -19% | -$14.5K | ﹤0.01% | 3479 |
|
|
2020
Q3 | $72.6K | Buy |
9,108
+7,926
| +671% | +$71.5K | ﹤0.01% | 3282 |
|
|
2020
Q2 | $11.7K | Sell |
1,182
-8,253
| -87% | -$75.8K | ﹤0.01% | 3639 |
|
|
2020
Q1 | $72.9K | Buy |
9,435
+5,169
| +121% | +$26.1K | ﹤0.01% | 3367 |
|
|
2019
Q4 | $16.4K | Sell |
4,266
-550
| -11% | -$2.4K | ﹤0.01% | 4050 |
|
|
2019
Q3 | $24.2K | Buy |
4,816
+1,424
| +42% | +$8.28K | ﹤0.01% | 3868 |
|
|
2019
Q2 | $22.4K | Sell |
3,392
-2,801
| -45% | -$19.2K | ﹤0.01% | 3855 |
|
|
2019
Q1 | $46.9K | Buy |
+6,193
| New | +$48.2K | ﹤0.01% | 3537 |
|
|
2018
Q4 | – | Sell |
-928
| Closed | -$12K | – | 4354 |
|
|
2018
Q3 | $12K | Hold |
928
| – | – | ﹤0.01% | 3649 |
|
|
2018
Q2 | $10.6K | Buy |
+928
| New | +$8.79K | ﹤0.01% | 3751 |
|
Other funds holding CTSO
AC
VCM
CM
SC
SIG
VFT
BNP Paribas Financial Markets's CTSO Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Cytosorbents Corp (CTSO) stake by 82% in Q2 2026, selling an estimated $7 and leaving 3 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5894.
BNP Paribas Financial Markets first reported a position in CTSO in Q2 2018 and has held it in 32 quarters since. The position peaked at $72.9K in Q1 2020. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.
- BNP Paribas Financial Markets held 3 shares of Cytosorbents Corp worth $1 as of Q2 2026.
- BNP Paribas Financial Markets sold 14 Cytosorbents Corp shares in Q2 2026, an estimated $7.
- Cytosorbents Corp made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5894 holding.
- BNP Paribas Financial Markets first reported a position in Cytosorbents Corp in Q2 2018 and has held it in 32 quarters since.
- BNP Paribas Financial Markets's Cytosorbents Corp position peaked at $72.9K in Q1 2020.
- 42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.